chrisvoncsefalvay/vaers-outcomes huggingface dataset:
poison Ivy; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program (159558). The reporter is the patient.  A female patient received BNT162b2 (BNT162B2), administration date 28Feb2021 (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DERMATITIS CONTACT (non-serious), outcome "unknown", described as "poison Ivy". Therapeutic measures were taken as a result of dermatitis contact. Additional information: Patient was taking prednisone for poison Ivy.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected
VAERS completed because of being Tested positive for COVID-19 infection 14 or more days after being fully vaccinated. 1st dose02/03/21 2nd dose02/24/21 Diagnosed covid positive:09/06/21 Symptom onset:09/06/21 Exposure:travel Symptoms:fatigue, muscle aches, loss of smell/taste
SORE ARM  NOSE CONGESTION FLUID IN EARS TENITIS HIGH PITH NOISE IN EAR SLIGHT HEARING LOSS
The soreness experienced continued  for a week to the day of the shot and on the 8th day until the present became increasingly unbearable. I'm unable to dress myself because the pain in my left arm is  excruciating.  I can't raise my arm  for more than a foot from my side.  I've taken ibuprofen  and am using ice compresses, but it doesn't help enough. So far I've missed 3 days of work.  I cannot dress myself, so I know I can't drive.  Please advise. I also massage the sore area to keep  my arm from stiffening up.
Pt. received vaccine few minutes later Pt complainted of blurred vision light headedness, dizziness. initial diff. breath took BP 130/75 HR 70 Took 1 tab Benadryl gave water
Pt presented with respiratory failure and sepsis reltated to covid pneumonia, he developed a saddle PE and DVTs. Pt was moved to hospice and expired. CT showed hepatic lesions suggesting metastatic disease.
Hives in hairline and forehead...itchy around the eyes.  Took oral antihistamine.
Pericarditis R-reactive proteins elevated large amounts of palpitations SOB with and without activity chest pain
Baby received Bexsero; Bexsero instead of Engerix-B; This non-serious case was reported by a other health professional via call center representative and described the occurrence of inappropriate age at vaccine administration in a 6-month-old male patient who received Men B NVS (Bexsero) (batch number 9R42C, expiry date 30-JUN-2024) for prophylaxis.   On 25-APR-2023, the patient received Bexsero. On 25-APR-2023, an unknown time after receiving Bexsero, the patient experienced inappropriate age at vaccine administration (Verbatim: Baby received Bexsero) and wrong vaccine administered (Verbatim: Bexsero instead of Engerix-B). The outcome of the inappropriate age at vaccine administration and wrong vaccine administered were unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK receipt date: 02-MAY-2023 Supervisor reported that a patient received Bexsero instead of a Hapatitis B vaccine Engerix-B. The reporter consented to follow up by email. The patient received Bexsero instead of Engerix-B at inappropriate age, which led to inappropriate age at vaccine administration and wrong vaccine administered.
Swelling, pain, itching at site of immunizations onset approx. 12 hrs after injections.  At onset, Dr. advised BENADRYL: by mouth and ice to site.  On 7/29/10, advised ZYRTEC and hydrocortisone to site.
None reported by the patient for 15 minutes of waiting time after  Moderna vaccine given.  Called patient 6 hours after and the call was not picked up.  Left message but haven't heard back.
Developed bradycardia. Resting heart rate was 62-65bpm prior to vaccine and is now 52-57bpm.
Site: Bruising at Injection Site-Mild, Site: Redness at Injection Site-Mild, Site: Swelling at Injection Site-Mild, Systemic: Numbness (specify: facial area, extremities)-Mild
6 hrs after neck stiffness,  Throat swell a little (like trying to get a cold, slight headache,   8 hrs headache worse took tylenol, 10 Hrs after  felt  like  a migrane , felt blood pressure elevated & took Ibuprofuen 800 mg,  that calmed my haeadache down , went to bed woke up in a sweat/ slight headache, after eating took another Ibruprofuen 800mg  & by 4pm headache was minimal,  took tylenol after that no more headache after 9 pm,   More tylenol before I went to bed , woke up fine  really tired did not go to work on monday, tuesday went to work still tired ,  wednesday woke up no problems felt refreshed.
Heavy arm one hour after intramuscular injection as well as minor redness.  Had a fever that evening.  Lymph nodes under left arm began swelling.  Extreme muscle/body aches.  Over the next week a low grade fever remained, some irregular breathing (perhaps due to the fever), lymph nodes under arm swelled to golf ball size, pain remained in the arm, extreme fatigue and arm pain.  Injection site bruise.  One month in and the under arm lymph node swelling has decreased though I still have pain in my upper arm and left trapezius as well as fatigue.
received the first dose / on  7/24/19 and had not yet received the second; This case was reported by a pharmacist via call center representative and described the occurrence of incomplete course of vaccination in a 73-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (received 1st dose on 24th July 2019).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.  Additional details were provided as follows: The age at vaccination was not applicable for this report. Till the time of reporting, the patient did not receive the 2nd dose of Shingrix as per the vaccination schedule, which led to incomplete course of vaccination. No further events were reported. The reporter consented to follow up.
This spontaneous report was received from a registered nurse and refers to a 12 month old patient of unknown gender. The patient's medical history, concurrent conditions and concomitant medications were not reported. On 14-JUL-2017, the patient was vaccinated with an improperly stored VARIVAX at a dose of 0.5 (units not specified) from lot # N012132 with expiry date: 17-APR-2019 (dose number, route, anatomical location and site of administration were not reported) for prophylaxis. Concomitant medications included a properly stored sterile diluent (manufacturer unknown). The administered dose of vaccine was stored in the temperature between 6 degrees Fahrenheit and 14 degrees Fahrenheit for 20 hours and in the temperature between 15 degrees Fahrenheit and 46 degrees Fahrenheit for 6 hours. There were no previous temperature excursions. Data logger was involved. No adverse effects were reported. No additional information was provided. This is one of the several reports received from the same reporter. Sender's Comments: US-009507513-1707USA004945.
Noticed raised bumps on leg at injection site at 9:15. At 9:30 noticed raised bumps on buttock and lower back. At 11:30 saw hives broken out all over both buttocks and thighs, also on lower back. Hives began to disappear at 4 PM. New hive appeared on lower leg at 4 PM. At 6 PM all hives disappeared, only slight redness remained.
No adverse effects were reported in the patient; A patient currently at the pharmacy received a dose of unknown hepatitis A vaccine 3 years ago and is currently at the pharmacy to get her second dose today.; This spontaneous report was received from a pharmacist, concerning to a female patient of unknown age. The patient's pertinent medical history, concurrent conditions, previously drug reactions or allergies, and concomitant therapies were not reported.  In approximately July 2016 (reported as 3 years ago), the patient went to the pharmacy, and was vaccinated with the first dose of hepatitis a vaccine, inactivated (manufacturer unknown) and on 30-JUL-2019 (reported as today), the patient went to the pharmacy to get her second dose of hepatitis a vaccine, inactivated (manufacturer unknown) both vaccines were administered as prophylaxis (strengths, formulations, doses, and anatomical locations vaccination were not reported;  expiration dates and lot numbers were unknown by the reported). No adverse effects were reported.
Patient had itching all over her body and used various ointments and sprays to relieve it. She has never had a reaction like this before. It started on her back Monday, but was almost entirely resolved by Saturday.
pt recv vax 24NOV97 & 27NOV97 pt exp a rip roaring bout of oral thrush & a severe case of vesicular classic varicella consisting of more than 500 lesions diffusely over body;T102 & h/a;
03/16/06-03/17/06 with high fever 102 Sunday pt woke up with hive like rash predominately in groin and lower torso area. Fever broke Friday. Pt also presented with poor appetite.
no adverse event  Wrongful vaccination of Moderna on 14 year old (indicated for 18+)
Patient experienced lip and tongue swelling around 30 minutes after vaccine administration. Patient was given epinephrine (EPIPEN).
Case number PHEH2012US016438 is a spontaneous report received initially from a nurse on 17 Aug 2012 and 20 Aug 2012 with a follow up information received from a nurse on 05 Sep 2012. This case refers to an 11-years-old female patient. Her medical history was not reported. Her concomitant vaccinations included ADACEL (other manufacturer, batch number: C4247AA,) and VARIVAX (other manufacturer, batch number: 0435A2) at a dose of 0.5 ml intramuscularly on 01 Aug 2012. She was vaccinated with MENVEO (batch number: M11075) intramuscularly on to left arm on 01 Aug 2012. On 03 Aug 2012, nurse reported that the patient experienced swollen, painful, bright red area 'size' of hand on three-quarters of the arm. The patient came to doctor's office on 06 Aug 2012, for evaluation of adverse events following MENVEO vaccine and her mother reported that the patient had onset of dizziness, fever with temperature of 104 degree F, nausea, decreased appetite, disorientation and sore throat with cough on and off all weekend. The area on arm was still slightly red and swollen. The reporter stated that she had a pretty remarkable local reaction; her arm was swollen all the way down to the elbow and it was kind of splotchy. She was still having fever during the doctor's visit. On 10 Aug 2012, she came back to doctor's office because of cold and upper respiratory symptoms, however her other symptoms had resolved. She only had a little residual rash at that time. On an unspecified date, she was hospitalized (date and duration of hospitalization was not reported). The outcome of the event was reported as complete recovery. The causality was not reported. Follow up information received on 05 Sep 2012: Patient demographics (initials, age, height and weight), concomitant vaccines, site of administration of MENVEO, events (dizziness, nausea, decreased appetite, disorientation, sore throat with cough, cold, upper respiratory symptoms and painful arm), seriousness and events outcome updated.
a "significant discomfort" on her lower back also described as being "pretty painful"; a "significant discomfort" on her lower back also described as being "pretty painful"; This is a spontaneous report from a contactable consumer. A 65-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), via an unspecified route of administration on Jan2021 (at the age of 65-years-old) as a single dose for COVID-19 immunization. Medical history and concomitant medications were not reported. The patient had no previous back injuries. On an unspecified date in Jan2021, the patient experienced a significant discomfort to her lower back also described as being "pretty painful" during the first two days post vaccination. The clinical outcome of a "significant discomfort" on her lower back also described as being "pretty painful" was resolving, reported as "much better today" and "almost" gone.  Information on lot/batch number has been requested.
11 year old was given an adult dose of Pfizer before it was noticed that she is 11. This was done at a 12 year + clinic which was not offering pediatric COVID vaccines. The mother was informed of what happened and is aware. The paperwork was also filled out by the mom for herself and not her daughter, so the paper consent form indicated she is pregnant/breast feeding but she is not, the mother is. No other action has been taken.
On the afternoon of December 1, 2022, I tested positive for COVID-19 using an antigen test kit.  I continue to test positive until the evening of December 5, 2022.  I exhibited mild symptoms (slight headache, nasal congestion) of COVID-19 during this time but none in the first few days after I first tested negative.  I obtained a prescription for Paxlovid from a doctor the afternoon I first tested positive and began taking it that evening.  I completed my course of Paxlovid on the morning of December 6, 2022.  During the night of December 9, 2022 I began exhibiting strong symptoms (headache, muscle soreness, nasal congestion, and cough) of COVID-19.  These symptoms have continued until the present time (the night of December 12, 2022).
Patient was given flu shot about 8:15 am. She then went to help a patient with breathing treatments in his room. She was masked and gloved.  When she came out of his room face was red pus bumps, itching on entire face but worse under mask. Today 10/03/2014 went into same persons room and came out red again, itching down arms. sent to ER.  Patient was given Solu Medrol in the ER.  We are thinking most likely a reaction to patients med he is getting instead of influenza shot. do to after talking with other staff when they are in patients room they start coughing, SOB, watery eyes. But because of also getting flu shot prior wanted to report.  Patients medication was a tube of Capsicum Oleoresine with 0.075% capsaicin.
dry cough/coughed all night; like choking; This spontaneous case was reported by a consumer and describes the occurrence of COUGH (dry cough/coughed all night) and CHOKING SENSATION (like choking) in a 79-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025B21A) for COVID-19 vaccination.     Concurrent medical conditions included Parkinson's disease.    On 15-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Apr-2021, the patient experienced COUGH (dry cough/coughed all night) and CHOKING SENSATION (like choking). At the time of the report, COUGH (dry cough/coughed all night) and CHOKING SENSATION (like choking) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported. No treatment information was provided. The patient received vaccination around 2:00.
Received Pfizer brand on first dose and second dose was Moderna; A spontaneous report was received from a nurse concerning a male patient who received Moderna's COVID-19 Vaccine (mRNA-1273) and received Pfizer brand on first dose and second dose was Moderna (wrong vaccine administered).   The patient's medical history was not provided.  Concomitant product use was not provided by the reporter.     On an unknown date, the patient received a dose of the Pfizer COVID vaccine.  On 07 Jan 2021, the patient received a dose of mRNA-1273 intramuscularly for prophylaxis of COVID-19 infection.    On 07 Jan 2021, the patient was administered mRNA-1273 vaccine for second dose instead of Pfizer COVID vaccine.   Treatment information was not provided.    Action taken with mRNA-1273 in response to the events was not provided.  The outcome of the events, received Pfizer brand on first dose and second dose was Moderna (wrong product administered), was resolved on 07 Jan 2021.; Reporter's Comments: This case concerns a male patient of unknown age who received their second of two planned doses of mRNA-1273 (Lot unknown), reporting Wrong product administered without any associated adverse events.
Janssen COVID-19 Vaccine EUA, single dose; prior infection and recovery from COVID-19 in November 2020; PCR-confirmed with symptoms.  One hour after injection, experience of nausea and crawling skin, recurring sensation of lightness in the chest. Following day, experience of fatigue, fever, sweats, tingling in the tongue, lips, and fingers, crawling skin, slight cough/scratchy throat, soreness in injection site.
Within 1 wk of vaccination rash began on fingers, hands, toes and feet. Bumpy rash, itchy. Did not seek medical treatment. Is resolving and areas are peeling now.
Received Dtap-IPV in deltoid, injection site red, and swollen about 4-5 inches. Area not tender.
arm hurt immed still hurts, diarrhea, very tired 1st & 2nd day p/immun;
tested positive by PCR for COVID 19 on 3/31/21, completed series of Pfizer COVID vaccine on 1/14/21.  Known exposure to household contacts with COVID 19.  Patient had N/V, abd pain.
GENERALISED ACHING; APPETITE LOST; SORE ARM; FEVER; NAUSEA; This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unk) dose was not reported, administered on 09-APR-2021 for prophylactic vaccination. Batch number was not reported. Per procedure, no follow up will be requested for this case. No concomitant medications were reported. On APR-2021, the subject experienced generalised aching. On APR-2021, the subject experienced appetite lost. On APR-2021, the subject experienced sore arm. On APR-2021, the subject experienced fever. On APR-2021, the subject experienced nausea. Laboratory data included: Body temperature (NR: not provided) 103. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from generalised aching, appetite lost, sore arm, fever, and nausea on APR-2021. This report was non-serious.
Initial report was received from a health care professional on 29 September 2009. A cluster of eight to ten patients out of 60 to 70 vaccinees had received an intramuscular injection of FLUZONE (lot number not reported) on 26 September 2009, and immediately within seconds, they experienced a black dot at the injection site after the needle was withdrawn from the deltoid muscle. The black dot could not be wiped off with gauze; however, it could be wiped off with an alcohol prep pad. The needles used to administer the vaccine were 25 gauge one inch in length and were manufactured by BD Dickinson; however, these needles were not used to draw up the vaccine. No additional symptoms were observed. One patient was prepubescent, one patient was a teen, and the remaining patients were adults. None of the patients had any concurrent illnesses and it was unknown if they had received any other vaccinations within four weeks prior to receipt of FLUZONE. All of the patients recovered. Follow-up information was received 13 October 2009 from a health care professional. The patient's had received FLUZONE, lot number U3213AA. No additional information was provided. Documents held by sender: None.
Symptoms included: headache, body aches, muscle aches, joint aches, stomach ache, nausea started out mild during the early morning hours on Friday, April 9, 2021, and  got progressively worse throughout the day and into the night of Friday.  Saturday morning, April 10th I felt fine.
Felt horrible starting in the middle of the night after receiving vaccination: Headache and aching all over (but especially in neck) Following onset of symptoms, took 1000mg acetominephen at 6 am, 12:30 pm, and 8:30 pm.  Spent most of day in bed and much of it sleeping. Second morning after vaccination: Left armpit swollen and very sore.  Neck still a little sore.  Still a little tired.  Other symptoms have abated.  May go back to bed for a few hours.
Severe swelling, pain, and bruising at and surrounding the injection site, including inside the armpit. Increasing symptoms throughout the past 24 hours
pt recv vax 24OCT95 & pt's mom reported to the nurse that on 30OCT95 pt exp a varicella-like rash w/50-100 lesions;no further details were provided;
Chills, pain in legs, back, neck, teeth, headache, chest pain, site pain, weakness, fatigue
Caller reports administration of ROTATEQ after temperature excursion; This spontaneous report was received from a reporter and refers to a patient of unknown age and gender. Information regarding the patient's concomitant therapies, concurrent conditions, medical history and historical drugs was not provided.  On 11-JAN-2021, the patient was vaccinated with improperly stored Rotavirus Vaccine, Live, Oral, Pentavalent (ROTATEQ) 2 milliliter oral route, lot # 1742457 and expiration date 06-JAN-2022 administered as prophylaxis.  The improperly stored dose of the suspect vaccine experienced a temperature excursion of 1.3 degree Celsius (°C) for 19 minutes on an unknown date; no previous temperature excursion were reported.  The call was made due to a digital data logger.   Lot No. 1742457 has been verified to be a valid lot number for Rotavirus Vaccine, Live, Oral, Pentavalent (ROTATEQ), expiration date reported as 16-FEB-2022, but upon internal validation established as 06-JAN-2022.
I suffer from psoriasis and whenever I catch a cold, I get something called guate psoriasis which looks like a splatter of my body. I only get them when I have a viral infection, so after my 2nd shot, these began to develop on my body. I would say about 2 weeks later from taking the vaccine. My doctor confirmed it was guate psoriasis. He gave me perezone which cleared it up. I had a 2nd wave of side effects as well, about 3 weeks or a month after. It was exactly the same as the initial side effects, flu like symptom's.
My son did and now he has the flu; Initial information received on 26-Nov-2022 regarding an unsolicited valid  non-serious case received from a patient. This case involves an unknown age male patient who experienced my son did and now he has the flu after receiving vaccine INFLUENZA VACCINE.  It was unknown if the patient experienced any additional symptoms/events.  It was unknown if the patient had any medical history, concomitant disease or risk factor.   On an unknown date, the patient received a suspect INFLUENZA VACCINE produced by unknown manufacturer(strength, dose, formulation, frequency, lot number and expiry date: not reported) via unknown route in unknown administration site for Flu(Influenza).  On an unknown date the patient developed a non-serious event my son did and now he has the flu (influenza) (unknown latency) following the administration of INFLUENZA VACCINE.  It was reported Medication Details and reason for taking the medicine: Product name was not provided. Since this is a public post we are assuming the consumer is referring to the Sanofi flu vaccine.  It was unknown if there were lab data/results available.   Action taken : Not applicable.  It was not reported if the patient received a corrective treatment for the event (My son did and now he has the flu).  At time of reporting, the outcome was Unknown for the event my son did and now he has the flu.
Severe HA with N/V to point mom was afraid pt would aspirate vomiting. Red faced and pale around mouth. Vomited so hard ans so much that veins burst on face. Received IV Phenergan and pain med.